Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

RENX to present at 40th JP Morgan Healthcare Conf.

January 5, 2022
RNS Number : 4318X Renalytix PLC 05 January 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Present at 40 th Annual J.P. Morgan Virtual Healthcare Conference   LONDON and SALT LAKE CITY , January 5, 2022 - Renalytix plc (LSE: RENX) (NASDAQ: RNLX) today announced the Company

Joint program with American Diabetes Association

January 4, 2022
RNS Number : 2538X Renalytix PLC 04 January 2022   Renalytix plc ("Renalytix" or the "Company")   American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population   National program establishes early care management, technology innovation and large

Result of AGM

December 17, 2021
RNS Number : 0925W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 17 December 2021   - Renalytix (NASDAQ: RNLX)  (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were

Director/PDMR Shareholding

December 17, 2021
RNS Number : 0593W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000

Director/PDMR Shareholding

December 13, 2021
RNS Number : 3617V Renalytix PLC 13 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of

Director/PDMR Shareholding

December 9, 2021
RNS Number : 1070V Renalytix PLC 09 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of

Director/PDMR Shareholding

December 8, 2021
RNS Number : 9024U Renalytix PLC 08 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950

Renalytix Reports Financial Results for Q1 of FY22

December 7, 2021
RNS Number : 7546U Renalytix PLC 07 December 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022   LONDON and SALT LAKE CITY , December 7, 2021   - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial

Notice of Q1 FY22 Results

December 2, 2021
RNS Number : 2978U Renalytix PLC 02 December 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7   LONDON and SALT LAKE CITY , December 2, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the

Publication of Annual Report 2021 & Notice of AGM

November 19, 2021
RNS Number : 0262T Renalytix PLC 19 November 2021     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2021 and Notice of 2021 Annual General Meeting   LONDON and SALT LAKE CITY , November 19, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual
Displaying 171 - 180 of 350